By - GBI Research
Summary
Research’s report: “Cardiac Rhythm Management Devices 2006 to 2020 – US & Europe” provides quantitative analysis of the four cardiac rhythm management devices market segments: cardiac resynchronization therapy devices, implantable cardioverter defibrillators, implantable loop recorders and pacemakers. The analysis includes market size data by revenue and volume over the 2006–2020 periods for the following countries: US, Germany, France, Italy, UK and Spain. It uses data and information sourced from proprietary databases, primary and secondary research and in-house analysis by Research’s team of industry experts.
Scope
Information on market size for the four cardiac rhythm management devices market segments: cardiac resynchronization therapy devices, implantable cardioverter defibrillators, implantable loop recorders and pacemakers
Annualized sales data by revenue for the 2006–2020 period and company share data by revenue for 2013
Annualized sales data by volume for the 2006–2020 period
Coverage of key geographies: China US, Germany, France, Italy, UK and Spain
Reasons to Buy
Derive actionable insights from value-volume relationships
Analyze value-volume relationships and provide direction to marketing and sales strategies
Develop market-entry and market-expansion strategies
Identify the key players best positioned to take advantage of opportunities in the US and European markets
View Complete Report @ http://www.lifescienceindustryresearch.com/market-snapshot-cardiac-rhythm-management-devices-2006-to-2020-us-and-europe.html .
Table of Contents
1 Table of Contents 1
1.1 List of Tables 4
1.2 List of Figures 6
2. GBI Research Report Guidance 8
3 Definitions 8
3.1 Cardiac Rhythm Management Devices 8
3.2 Cardiac Resynchronization Therapy Devices 9
3.2.1 Cardiac Resynchronization Therapy – Defibrillators 9
3.2.2 Cardiac Resynchronization